Type 2 diabetes drug may lead to excessive acid in the blood and UTI, FDA warns

"The U.S. Food and Drug Administration (FDA) has added warnings to the labels of a specific class of type 2 diabetes medicines, after a safety review showed it may lead to having too much acid in the blood and serious urinary tract infections.

Sodium-glucose cotransporter-2, or SGLT2 inhibitors, refers to a class of prescription medicines that FDA approved to lower blood sugar in adults with type 2 diabetes. It is not, however, approved by the agency for use in patients with type 1 diabetes."

Click here to read the full article

Source- http://www.ibtimes.com.au/type-2-diabetes-drug-may-lead-excessive-acid-blood-uti-fda-warns-1490537


Must Read